LTZ Therapeutics
Develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
Employees
Enterprise value
$400m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor investor investor investor | €0.0 Valuation: €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
* | $40.0m Valuation: $400m | Series A | |
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads